Yesterday, Lou revealed the specific sector that’s set to outperform right now: Biotech. Simply put, given what’s happening with the coronavirus, if you invest in the right biotech companies, you could earn huge returns.
Tomorrow, we’ll be hosting a crucial Investment Briefing about the coronavirus. During the event, my colleague Lou will explain why — for scientists, healthcare experts, and investors — the most important number right now is 263.
As Lou explained yesterday, even with the market getting clobbered because of the coronavirus, individual stocks can still generate big profits. That’s why Lou showed you a handful of names he believes will rally.
As Lou and Matt explained earlier this week, stocks are in for a bumpy ride. With multiple crises happening at once, things will likely get worse before they get better.
Yesterday, Lou shared his research on how previous health crises impacted the markets. As he explained, epidemics like SARS and Ebola took a nasty toll.
If you’ve been following the news recently, you’re already aware of the global health crisis affecting the stock market: A disease known as the coronavirus has been wreaking havoc. Chinese factories have come to a screeching halt.